Skip to navigation bar Skip to breadcrumbs Skip to page content
clear place holder
Envelope icon E-mail Updates Teal square Text size:  a A A

Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication

Release Date: January 2017

Recommendation Summary

PopulationRecommendationGrade
(What's This?)
Women who are planning or capable of pregnancy

The USPSTF recommends that all women who are planning or capable of pregnancy take a daily supplement containing 0.4 to 0.8 mg (400 to 800 µg) of folic acid.

A

To read the recommendation statement in JAMA, select here.

To read the evidence summary in JAMA, select here.

Related Information for Consumers

There is no related information for consumers.

Related Information for Health Professionals

There is no related information for health professionals.

Clinical Summary

Clinical summaries are one-page documents that provide guidance to primary care clinicians for using recommendations in practice.

This summary is intended for use by primary care clinicians.

 
Current as of: January 2017

Internet Citation: Final Update Summary: Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication. U.S. Preventive Services Task Force. January 2017.
https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication

USPSTF Program Office   5600 Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857